Eris Lifesciences Limited has informed the Exchange about Schedule of meet
ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eris Lifesciences Limited has submitted a Schedule of Meeting intimation to the stock exchange. The filing itself does not specify the type of meeting (board, audit committee, or investor), the date, or the agenda items to be discussed. Investors should wait for the detailed meeting notice or the outcome announcement for specifics on any decisions taken.
As this is a preliminary intimation with no disclosed agenda or outcomes, it is a procedural compliance filing and is unlikely to have an immediate impact on the stock price. Shareholders should watch for the subsequent outcome filing for any material business or financial decisions.